David Kleinman

582 total citations
36 papers, 375 citations indexed

About

David Kleinman is a scholar working on Molecular Biology, Ophthalmology and Hematology. According to data from OpenAlex, David Kleinman has authored 36 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Ophthalmology and 11 papers in Hematology. Recurrent topics in David Kleinman's work include Multiple Myeloma Research and Treatments (11 papers), Retinal Diseases and Treatments (5 papers) and Retinal Imaging and Analysis (4 papers). David Kleinman is often cited by papers focused on Multiple Myeloma Research and Treatments (11 papers), Retinal Diseases and Treatments (5 papers) and Retinal Imaging and Analysis (4 papers). David Kleinman collaborates with scholars based in United States, United Kingdom and Canada. David Kleinman's co-authors include Wayne Solley, George A. Williams, Pravin U. Dugel, Julia A. Haller, James V. Aquavella, Mark S. Blumenkranz, Joel Naor, David DiLoreto, Francis E. Marchlinski and Mina Chung and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

David Kleinman

34 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Kleinman United States 10 137 125 110 59 57 36 375
Matthew R. Hosler United States 10 61 0.4× 18 0.1× 201 1.8× 99 1.7× 43 0.8× 13 375
Frank Ierino Australia 10 18 0.1× 144 1.2× 146 1.3× 25 0.4× 14 0.2× 17 383
Serife Canturk Türkiye 5 262 1.9× 62 0.5× 52 0.5× 28 0.5× 106 1.9× 9 316
Rita S. Sitorus Indonesia 8 302 2.2× 135 1.1× 83 0.8× 36 0.6× 94 1.6× 28 412
Chantal Farra Lebanon 12 18 0.1× 18 0.1× 71 0.6× 42 0.7× 27 0.5× 38 341
Laurence Detourmignies France 9 11 0.1× 31 0.2× 195 1.8× 86 1.5× 100 1.8× 16 402
Hamid Ehsan United States 10 10 0.1× 34 0.3× 67 0.6× 9 0.2× 116 2.0× 46 341
M Binaghi France 12 183 1.3× 90 0.7× 34 0.3× 37 0.6× 6 0.1× 35 518
Xia Song China 11 119 0.9× 101 0.8× 59 0.5× 4 0.1× 133 2.3× 48 353
A. Stamatoulas France 5 17 0.1× 14 0.1× 286 2.6× 76 1.3× 52 0.9× 9 449

Countries citing papers authored by David Kleinman

Since Specialization
Citations

This map shows the geographic impact of David Kleinman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Kleinman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Kleinman more than expected).

Fields of papers citing papers by David Kleinman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Kleinman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Kleinman. The network helps show where David Kleinman may publish in the future.

Co-authorship network of co-authors of David Kleinman

This figure shows the co-authorship network connecting the top 25 collaborators of David Kleinman. A scholar is included among the top collaborators of David Kleinman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Kleinman. David Kleinman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kleinman, David, et al.. (2024). PLL-g-PEG Polymer Inhibits Antibody-Drug Conjugate Uptake into Human Corneal Epithelial Cells In Vitro. Journal of Ocular Pharmacology and Therapeutics. 40(7). 419–427. 2 indexed citations
2.
Ailawadhi, Sikander, Rakesh Popat, David Kleinman, et al.. (2023). Treatment preferences of patients with relapsed or refractory multiple myeloma in the United States, United Kingdom, Italy, Germany, France, and Spain: results from a discrete choice experiment. Frontiers in Medicine. 10. 1271657–1271657. 9 indexed citations
3.
Huvard, Michael J., Jennifer L. Patnaik, David Kleinman, et al.. (2023). An Evaluation of the Repeatability of Visual Function Following Surgical Repair of Macula-Off Rhegmatogenous Retinal Detachment. Translational Vision Science & Technology. 12(11). 35–35. 1 indexed citations
4.
Hultcrantz, Malin, David Kleinman, Ravi Vij, et al.. (2023). Belantamab mafodotin (belamaf) for relapsed/refractory multiple myeloma (RRMM): A real-world observational study update.. Journal of Clinical Oncology. 41(16_suppl). e20046–e20046. 1 indexed citations
5.
Popat, Rakesh, Sagar Lonial, Peter M. Voorhees, et al.. (2023). Patient-Reported Outcomes With Belantamab Mafodotin Treatment in Patients With Triple-Class Refractory Multiple Myeloma. Journal of the Advanced Practitioner in Oncology. 14(6). 503–518. 3 indexed citations
6.
7.
8.
Chen, Andrew, Mina Chung, Rajeev S. Ramchandran, et al.. (2020). Quantitative Comparison of Fundus Images by 2 Ultra-Widefield Fundus Cameras. Ophthalmology Retina. 5(5). 450–457. 18 indexed citations
9.
Ho, Allen C., David Kleinman, Flora Lum, et al.. (2020). Baseline Visual Acuity at Wet AMD Diagnosis Predicts Long-Term Vision Outcomes: An Analysis of the IRIS Registry. Ophthalmic surgery, lasers & imaging retina. 51(11). 633–639. 21 indexed citations
10.
Nowak, Dawid G., Hyejin Cho, Tali Herzka, et al.. (2015). MYC Drives Pten/Trp53 -Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2. Cancer Discovery. 5(6). 636–651. 64 indexed citations
11.
12.
Gensheimer, William G., David Kleinman, Eugene R. Cooper, et al.. (2012). Novel Formulation of Glycerin 1% Artificial Tears Extends Tear Film Break-Up Time Compared with Systane Lubricant Eye Drops. Journal of Ocular Pharmacology and Therapeutics. 28(5). 473–478. 19 indexed citations
13.
Dugel, Pravin U., Mark S. Blumenkranz, Julia A. Haller, et al.. (2011). A Randomized, Dose-Escalation Study of Subconjunctival and Intravitreal Injections of Sirolimus in Patients with Diabetic Macular Edema. Ophthalmology. 119(1). 124–131. 49 indexed citations
14.
Kim, David D., David Kleinman, Mary E. Gerritsen, et al.. (2010). Rapamycin Inhibits VEGF-Induced Microvascular HyperpermeabilityIn Vivo. Microcirculation. 17(2). 128–136. 15 indexed citations
15.
Kleinman, David, et al.. (2007). Sirolimus Inhibits VEGF-Induced Microvascular Hyperpermeability. 48(13). 1422–1422. 4 indexed citations
16.
Lam, Wai‐Ching, et al.. (2003). Retinopathy in sickle cell trait: Does it exist?. Canadian Journal of Ophthalmology. 38(1). 46–51. 15 indexed citations
17.
Honigman, Benjamin, et al.. (2001). Case Report: High Altitude Retinal Hemorrhages in a Colorado Skier. High Altitude Medicine & Biology. 2(4). 539–544. 15 indexed citations
18.
Marchlinski, Francis E., et al.. (1998). Magnetic Electroanatomical Mapping for Ablation of Focal Atrial Tachycardias. Pacing and Clinical Electrophysiology. 21(8). 1621–1635. 42 indexed citations
19.
Kleinman, David & Stephen L. Winters. (1996). Successful catheter ablation of an inferoseptal accessory pathway within the coronary sinus in a patient with a previously unsuccessful attempt at surgical interruption. Journal of Electrocardiology. 29(1). 55–60. 3 indexed citations
20.
Kleinman, David, et al.. (1990). Combined anesthetic and surgical treatment of reflex sympathetic dystrophy following a healed crush injury of the foot.. PubMed. 29(1). 55–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew R. Hosler Breakdown of academic impact, for papers by Frank Ierino Breakdown of academic impact, for papers by Serife Canturk Breakdown of academic impact, for papers by Rita S. Sitorus Breakdown of academic impact, for papers by Chantal Farra Breakdown of academic impact, for papers by Laurence Detourmignies Breakdown of academic impact, for papers by Hamid Ehsan Breakdown of academic impact, for papers by M Binaghi Breakdown of academic impact, for papers by Xia Song Breakdown of academic impact, for papers by A. Stamatoulas
Rankless by CCL
2026